Delivery Order SPE2DR25D3103-SPE2DR26F9H42
Award Date 11/20/25
Potential Completion Date 11/21/25
Potential Value $9.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The $2,609.26 firm fixed-price contract has a completion date of June 28, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Multihance 529mg/ml. The delivery order, valued at $5,323.05, has a firm fixed price and an ultimate completion date of March 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,513.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC allows Amerisourcebergen to deliver a...
- The Defense Logistics Agency (DLA) awarded a $2,704.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,989.50 firm fixed-price Delivery Order, awarded on November 8, 2022, is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The contract has an ultimate completion date of November 9, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $8,776.50 and a period of performance through January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML medical products. The contract, valued at $6,100.40, is a firm fixed-price delivery order with a completion date of September 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,666.54 to AmerisourceBergen Drug Corp for the supply of Multihance 529mg/ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 21, 2025, represents a non-competitive award under an existing indefinite delivery contract. The product will be delivered to the company's corporate office location in...
- This is a federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,208.48, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a significant Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for PROHANCE 279.3 mg/mL vials (20 mL) valued at $2,096.19. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 17, 2025. The award was made on November 14, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at approximately $1 billion and extending through...